You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Vol. 36 Issue 10

November 2012

Volume 36, Issue 10

Pages 909–995

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
  2. META-ANALYSES

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
      Meta-analysis: adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test (pages 929–940)

      C. Hassan, P. Giorgi Rossi, L. Camilloni, D. K. Rex, B. Jimenez-Cendales, E. Ferroni, P. Borgia, A. Zullo, G. Guasticchi and HTA Group

      Version of Record online: 4 OCT 2012 | DOI: 10.1111/apt.12071

  3. PPIS AND PNEUMONIA

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia (pages 941–949)

      C. P. C. de Jager, P. C. Wever, E. F. A. Gemen, M. G. H. van Oijen, A. B. van Gageldonk-Lafeber, P. D. Siersema, G. C. M. Kusters and R. J. F. Laheij

      Version of Record online: 3 OCT 2012 | DOI: 10.1111/apt.12069

  4. EOSINOPHILIC OESOPHAGITIS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study (pages 950–958)

      A. A. N. Syed, C. N. Andrews, E. Shaffer, S. J. Urbanski, P. Beck and M. Storr

      Version of Record online: 20 SEP 2012 | DOI: 10.1111/apt.12053

  5. LONG-TERM PPI SAFETY

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial (pages 959–971)

      R. Fiocca, L. Mastracci, S. E. Attwood, C. Ell, J.-P. Galmiche, J. Hatlebakk, A. Bärthel, G. Långström, T. Lind, L. Lundell and the LOTUS trial collaborators

      Version of Record online: 23 SEP 2012 | DOI: 10.1111/apt.12052

  6. HELICOBACTER PYLORI

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin (pages 972–979)

      E. A. Marcus, N. Inatomi, G. T. Nagami, G. Sachs and D. R. Scott

      Version of Record online: 25 SEP 2012 | DOI: 10.1111/apt.12059

  7. FRUCTOSE MALABSORPTION

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
  8. INVITED COMMENTARIES

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
    2. You have free access to this content
  9. LETTERS TO THE EDITORS

    1. Top of page
    2. REVIEW ARTICLE
    3. META-ANALYSES
    4. PPIS AND PNEUMONIA
    5. EOSINOPHILIC OESOPHAGITIS
    6. LONG-TERM PPI SAFETY
    7. HELICOBACTER PYLORI
    8. FRUCTOSE MALABSORPTION
    9. INVITED COMMENTARIES
    10. LETTERS TO THE EDITORS
    1. You have free access to this content
      Letter: carbon dioxide vs. room air insufflation for gastrointestinal endoscopy (page 990)

      M. Bhalme, F. Kidd, J. Ramesh and D. Martin

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12048

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B (pages 992–993)

      S. Manolakopoulos, A. Striki and G. V. Papatheodoridis

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12065

    5. You have free access to this content
    6. You have free access to this content
      Letter: sorafenib in portal hypertension (page 994)

      B. Procopet, C. Bureau and J. M. Peron

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12067

    7. You have free access to this content
      Letter: sorafenib in portal hypertension – authors' reply (pages 994–995)

      M. Peck-Radosavljevic, M. Pinter, T. Reiberger, A. Ferlitsch and W. Sieghart

      Version of Record online: 16 OCT 2012 | DOI: 10.1111/apt.12077

SEARCH

SEARCH BY CITATION